Delayed-late activation of a myeloid defensin minimal promoter by retinoids and inflammatory mediators

Leukemia Research

Volumn 28, Issue 8, 2004, Pages 879-889

  Wang, Nan ^a   Su, Qin ^a   Boeckh Herwig, Susanne ^a   Yaneva, Mariana ^a   Tempst, Paul ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

cAMP; Defensin; Granulocytes; Phosphorylation; Retinoic acid; Transcription

Indexed keywords

ALPHA DEFENSIN; AUTACOID; CYCLIC AMP; LIPOPOLYSACCHARIDE; RETINOIC ACID; RETINOID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL SPECIFICITY; CELL STRAIN HL 60; CORRELATION ANALYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION;

ALPHA-DEFENSINS; ANTINEOPLASTIC AGENTS; BINDING SITES; CYCLIC AMP; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HELA CELLS; HL-60 CELLS; HUMANS; LIPOPOLYSACCHARIDES; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RETINOIDS; SEQUENCE DELETION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2942529174     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.12.005     Document Type: Article

References (37)

1. Koeffler H.P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood. 62:1983;709-721
2. Collins S.J. The HL-60 promyelocytic leukemia cell line: proliferation. Blood. 70:1987;1233-1244
3. Breitman T.R., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 77:1980;2936-2940
4. Herwig S., Su Q., Zhang W., Ma Y., Tempst P. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells. Blood. 87:1996;350-364
5. Lehrer R.I., Lichtenstein A.K., Ganz T. Defensins, antimicrobial and cytotoxic peptides of mammalian cells. Ann. Rev. Immunol. 11:1993;105-128
6. Lehrer R.I., Ganz T. Defensins of vertebrate animals. Curr. Opin. Immunol. 4:2002;96-102
7. Zhang L., Yu W., He T., Yu J., Caffrey R.E., Dalmano E.A., et al. Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science. 298:2002;995-1000
8. Wiedemann L.M., Francis G.E., Lamb R.F., Burns J.H., Winnie J.N., McKenzie E.D., et al. Differentiation stage-specific expression of a gene during granulopoiesis. Leukemia. 3:1989;227-234
9. Mars W.M., Florine D.L., Talpaz M., Saunders G.F. Preferentially expressed genes in chronic myelogenous leukemia. Blood. 65:1985;1218-1225
10. Ma Y., Su Q., Tempst P. Differentiation-stimulated activity binds an ETS-like, essential regulatory element in the human promyelocytic defensin-1 promoter. J. Biol. Chem. 273:1998;8727-8740
11. Tsutsumi-Ishii Y., Hasebe T., Nagaoka I. Role of CCAAT/enchancer-binding protein site in transcription of human neutrophil peptide-1 and -3 defensin genes. J. Immunol. 164:2000;3264-3273
12. Herwig S., Su Q., Tempst P. Drug-activated multiple pathway of defensin mRNA regulation in HL-60 cells are defined by reversed roles of participating protein kinases. Leukemia Res. 22:1998;913-925
13. Tenen D.G., Hromas R., Licht J.D., Zhang D.-E. Transcription factors, normal myeloid development, and leukemia. Blood. 90:1997;489-519
14. Friedman A.D. Transcriptional regulation of granulocyte and monocyte development. Oncogene. 21:2002;3377-3390
15. Holmberg C.I., Tran S.E.F., Eriksson J.E., Sistonen L. Multisite phosphorylation provides sophisticated regulation of transcription factors. TIBS. 27:2002;619-627
16. Daher K.A., Lehrer R.I., Ganz T., Kronenberg M. Isolation and characterization of human defensin cDNA clones. Proc. Natl. Acad. Sci. U.S.A. 85:1988;7327
17. Zhang D.-E., Heterington C.J., Chen H.-M., Tenen D.G. The macrophage transcription factor PU.1 directs tissue-specific expression of the MCSF receptor. Mol. Cell. Biol. 14:1994;373-381
18. Lalli E., Sassoni-Corsi P. Signal transduction and gene regulation: the nuclear response to cAMP. J. Biol. Chem. 269:1994;17359-17362
19. Sweet M.J., Hume D.A. Endotoxin singal transduction in macrophages. J. Leukocyte Biol. 60:1996;8-26
20. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 13:2001;85-94
21. Baud V., Karim M. Signal transduction by tumor necrosis factor and its relatives. TICB. 11:2001;372-377
22. Reinhard C., Shamoon B., Shyamala V., Williams L.T. Tumor necrosis factor a-induced activation of c-jun N-terminal kinase is mediated by TRAF2. EMBO J. 16:1997;1080-1092
23. Bialojan C., Takai A. Inbibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Biochem. J. 256:1988;283-290
24. Dounay A.B., Forsyth C.J. Okadaic Acid: the archetypal serine-threonine protein phosphatase inhibitor. Curr. Med. Chem. 9:2002;1939-1980
25. Rohlff C., Ahmad S., Borellini F., Lei J., Glazer R.I. Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J. Biol. Chem. 272:1997;21137-21141
26. Zhong H., Yang H.S., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cAMP-independent mechanism. Cell. 89:1997;413-424
27. Tsai E.Y., Falvo J.V., Tsytsykova A.V., Barczak A.K., Reimold A.M., Glimcher L.H., et al. A lipopolysaccharide-specific enchancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol. Cell. Biol. 20:2000;6084-6094
28. Groupp E.R., Donovan-Peluso M. Lipopolysaccharide induction of THP-1 cells activates binding oc c-Jun, Ets, and Egr-1 to the tissue factor promoter. J. Biol. Chem. 271:1996;12423-12430
29. Shackelford R., Adams D.O., Johnson S.P. IFN-gamma and lipopolysacchride induce DNA binding of transcription factor PU.1 in murine tissue macrophages. J. Immunol. 154:1995;1374-1382
30. Lodie T.A., Savedra R. Jr., Golenbock D.T., Van Beveren C.P., Maki R.A., Fenton M.J. Stimulation of macrophages by lipopolysacchride alters the phosphorylation state, conformation. J. Immunol. 158:1997;1848-1856
31. Dusi S., Donini M., Lissandrini D., Mazzi P., Bianca V.D., Rossi F., et al. Mechanisms of expression of NADPH oxidase components in human cultured monocytes: role of cytokines and transcriptional regulations involved. Eur. J. Immunol. 31:2001;929-938
32. Pevzner V., Kraft R., Kostka S., Lipp M. Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability. Biochem. J. 347:2000;29-35
33. Finch J.S., Rosenberger S.F., Martinez J.D., Bowden G.T. Okadaic acid induces transcription of junB through a CCAAT box and NF-Y. Genetics. 267:2001;135-144
34. Sementchenko V.I., Watson D.K. Ets target genes: past, present and future. Oncogene. 19:2000;6533-6548
35. Skalnik D.G. Transcriptional mechanisms regulating myeloid-specific genes. Genetics. 284:2002;1-21
36. Mao C., Ray-Gallet D., Tavitian A., Moreau-Gachelin F. Differential phosphorylations of Spi-B and Spi-1 transcription factors. Oncogene. 12:1996;863-873
37. Rieske P., Pongubala J.M.R. AKT Induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain. J. Biol. Chem. 276:2001;8460-8468